Use of medical services by Methylphenidate-treated children in the general population

Ambulatory Pediatrics

Volumn 4, Issue 2, 2004, Pages 174-180

  Miller, Anton R ^a   Brehaut, Jamie C ^c   Raina, Parminder ^a,b,d   McGrail, Kimberlyn M ^b   Armstrong, Robert W ^a,b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Administrative data; Attention deficit hyperactivity disorder; Children; Health services use; Injuries; Population based research

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CANADA; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DATA BASE; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PRACTITIONER; HUMAN; INFANT; INTENSIVE CARE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY; SUPPORT GROUP;

EID: 1842582722     PISSN: 15301567     EISSN: None     Source Type: Journal    
DOI: 10.1367/A03-031R1.1     Document Type: Article

References (38)

1. Scahill L, Schwab-Stone M. Epidemiology of ADHD in schoolage children. Child Adolesc Psychiatr Clin N Am. 2000;9:541-555.
2. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. New York, NY: Guildford Press; 1998.
3. Wender EH. Attention-deficit/hyperactivity disorder: Is it common? Is it overtreated? Arch Pediatr Adolesc Med. 2002;156: 209-210.
4. Evenson B. The trouble with Ritalin. National Post. April 2, 2001;News:A8.
5. Safer DJ, Zito JM. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. In: Greenhill LL, Osman BB, eds. Ritalin. Theory and Practice. New York, NY: Mary Anne Liebert; 2000: 7-26.
6. Brehaut JC, Miller A, Raina P, McGrail KM. Childhood behavior disorders and injuries among children and youth: A population-based study. Pediatrics. 2003;111:262-269.
7. Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:71-78.
8. Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001;285:60-66.
9. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: National estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 2002;156:504-511.
10. Chamberlayne R, Green B, Barer ML, et al. Creating a population-based linked health database: A new resource for health services research. Can J Public Health. 1998;89:270-273.
11. Dosa NP, Boeing NM, Ms N, Kanter RK. Excess risk of severe acute illness in children with chronic health conditions. Pediatrics. 2001;107:499-504.
12. DiScala C, Lescohier I, Barthel M, Li G. Injuries to children with attention deficit hyperactivity disorder. Pediatrics. 1998; 102:1415-1421.
13. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA. 1998;280:1569-1575.
14. Simpson N, Roman K. Complementary medicine use in children: extent and reasons. A population-based study. Br J Gen Pract. 2001;51:914-916.
15. Adesman AR, Altshuler LA, Lipkin PH, Walco GA. Otitis media in children with learning disabilities and in children with attention deficit disorder with hyperactivity. Pediatrics. 1990; 85:442-446.
16. Grundfast KM, Berkowitz RG, Conners CK, Belman P. Complete evaluation of the child identified as a poor listener. Int J Pediatr Otorhinolaryngol. 1991;21:65-78.
17. Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy. 1994;72:462-468.
18. Tryphonas H, Trites R. Food allergy in children with hyperactivity, learning disabilities and/or minimal brain dysfunction. Ann Allergy. 1979;42:22-27.
19. British Columbia Provincial Health Officer. A report on the health of British Columbians: Provincial Health Officer's annual report 1999. Victoria, BC: Ministry of Health and Ministry Responsible for Seniors; 2000.
20. Ng E, Wilkins R, Perras A. How far is it to the nearest hospital? Calculating distances using the Statistics Canada Postal Code Conversion File. Health Rep. 1993;5:179-188.
21. Health Canada. Survey of attention deficit hyperactivity disorder diagnosis and treatment among Canadian physicians. Final report. Ottawa, ON: Health Canada, Therapeutic Products Program; 1999.
22. Ruel JM, Hickey CP. Are too many children being treated with methylphenidate? Can J Psychiatry. 1992;37:570-572.
23. Boles M, Lynch FL, DeBar LL. Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. J Child Adolesc Psychopharmacol. 2001;11:43-52.
24. Rowland AS, Umbach DM, Stallone L, et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health. 2002;92:231-234.
25. Barbaresi WJ, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med 2002;156:217-224.
26. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:85S-121S.
27. Chermak GD, Somers EK, Seikel JA. Behavioral signs of central auditory processing disorder and attention deficit hyperactivity disorder. J Am Acad Audiol. 1998;9:78-84.
28. McGee R, Stanton WR, Sears MR. Allergic disorders and attention deficit disorder in children. J Abnorm Child Psychol. 1993;21:79-88.
29. Gaitens T, Kaplan BJ, Freigang B. Absence of an association between IgE-mediated atopic responsiveness and ADHD symptomatology. J Child Psychol Psychiatry. 1998;39:427-431.
30. Carter CM, Urbanowicz M, Hemsley R, et al. Effects of a few food diet in attention deficit disorder. Arch Dis Child. 1993;69: 564-568.
31. Vickers A, Zollman C. ABC of complementary medicine. The manipulative therapies: Osteopathy and chiropractic. BMJ. 1999; 319:1176-1179.
32. Brue AW, Oakland TD. Alternative treatments for attention-deficit/hyperactivity disorder: Does evidence support their use? Altern Ther Health Med. 2002;8:68-70,72-64.
33. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246-252.
34. Kozyrskyj AL, Mustard CA. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998; 32:1152-1157.
35. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48:999-1009.
36. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666-674.
37. Roos LL, Roos NP, Cageorge SM, Nicol JP. How good are the data? Reliability of one health care data bank. Med Care. 1982; 20:266-276.
38. Roos LL, Nicol JP, Johnson CF, Roos NP. Using administrative databanks for research and evaluation. Evaluation Quarterly. 1979;3:236-255.